Tolero Pharmaceuticals Presents Preliminary Findings from Phase 1 Study Evaluating Investigational Agent TP-0903 in Patients with Advanced Solid Tumors at ESMO 2019
SUMITOMO CHEM UNSP/ADR (SOMMY)
NASDAQ:AMEX Investor Relations:
sumitomo-chem.co.jp/english/ir
Company Research
Source: PR Newswire
SALT LAKE CITY, Sept. 28, 2019 /PRNewswire/ -- Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today presented new data from the ongoing Phase 1 study evaluating the maximum tolerated dose (MTD) of the oral investigational agent TP-0903, an AXL receptor tyrosine kinase (RTK) inhibitor, in patients with advanced solid tumors. These results were presented in a poster presentation at the 2019 European Society for Medical Oncology (ESMO) meeting, being held September 27-October 1, 2019, in Barcelona, Spain. Preliminary findings of the Phase 1a dose-escalation part of the study indicate that TP-0903 was well tolerated with a manageable safety profile. In the study, 34 of 38 total patients were evaluable and received escalating doses of oral TP-0903 from 1.5 to 37 mg/m2 and 50 mg flat dosing once-daily in 21 of 28-day cycles. Fifteen patients remained on the study for more than four cycles, despite a
Show less
Read more
Impact Snapshot
Event Time:
SOMMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOMMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOMMY alerts
High impacting SUMITOMO CHEM UNSP/ADR news events
Weekly update
A roundup of the hottest topics
SOMMY
News
- Poxel Reports Cash and Revenue for the Third Quarter and Nine Months 2024 and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Xavier Creative House Hires Jami Rogers as Vice President of Sales & Marketing [Yahoo! Finance]Yahoo! Finance
- 3 Japanese Stocks Estimated To Be Up To 39.6% Below Intrinsic Value [Yahoo! Finance]Yahoo! Finance
- Rio Tinto Completes the Acquisition of 11.65% Stake in Boyne Smelters [Yahoo! Finance]Yahoo! Finance
- Poxel Reports Financial Results for Full Year 2023 and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance